Retour
Fourchette du Jour
202,26 €
207,23 €
Fourchette 52 Semaines
109,82 €
247,21 €
Volume
754 318
Moyenne 50J / 200J
213,36 €
/
194,00 €
Clôture Précédente
200,35 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 12,7 | 0,4 |
| P/B | 4,2 | 2,9 |
| ROE % | 33,5 | 3,8 |
| Net Margin % | 6,6 | 3,9 |
| Rev Growth 5Y % | 2,3 | 10,0 |
| D/E | 3,1 | 0,2 |
Objectif de Cours des Analystes
Hold
258,55 €
+27.1%
Low: 224,00 €
High: 288,00 €
P/E Prévisionnel
11,9
BPA Prévisionnel
17,16 €
Croissance BPA (est.)
+0,0%
CA Est.
22 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
23,74 €
23,20 € – 24,30 €
|
24 B | 2 |
| FY2028 |
19,99 €
16,13 € – 22,12 €
|
24 B | 4 |
| FY2027 |
17,56 €
15,32 € – 20,52 €
|
22 B | 12 |
Points Clés
Revenue grew 2,26% annually over 5 years — modest growth
Earnings declined -56,03% over the past year
ROE of 33,54% indicates high profitability
Debt/Equity of 3,12 — high leverage
Generating 2,53B in free cash flow
P/E of 12,71 — trading at a low valuation
Croissance
Revenue Growth (5Y)
2,26%
Revenue (1Y)3,12%
Earnings (1Y)-56,03%
FCF Growth (3Y)24,85%
Qualité
Return on Equity
33,54%
ROIC15,13%
Net Margin6,60%
Op. Margin16,46%
Sécurité
Debt / Equity
3,12
Current Ratio1,76
Interest Coverage0,00
Valorisation
P/E Ratio
12,71
P/B Ratio4,24
EV/EBITDA8,03
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,12% | Revenue Growth (3Y) | 1,84% |
| Earnings Growth (1Y) | -56,03% | Earnings Growth (3Y) | 51,75% |
| Revenue Growth (5Y) | 2,26% | Earnings Growth (5Y) | 11,39% |
| Profitability | |||
| Revenue (TTM) | 21,31B | Net Income (TTM) | 1,41B |
| ROE | 33,54% | ROA | 4,74% |
| Gross Margin | 41,41% | Operating Margin | 16,46% |
| Net Margin | 6,60% | Free Cash Flow (TTM) | 2,53B |
| ROIC | 15,13% | FCF Growth (3Y) | 24,85% |
| Safety | |||
| Debt / Equity | 3,12 | Current Ratio | 1,76 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 12,71 | P/B Ratio | 4,24 |
| P/S Ratio | 0,84 | PEG Ratio | -0,24 |
| EV/EBITDA | 8,03 | Dividend Yield | 0,00% |
| Market Cap | 17,88B | Enterprise Value | 28,16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21,31B | 20,67B | 20,55B | 19,17B | 19,49B |
| Net Income | 1,41B | 3,20B | 611,00M | 411,00M | 914,00M |
| EPS (Diluted) | 15,49 | 32,70 | 5,71 | 3,79 | 8,42 |
| Gross Profit | 8,83B | 8,21B | 7,81B | 7,05B | 7,27B |
| Operating Income | 3,51B | 5,96B | 2,51B | 2,33B | 2,87B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,68B | 28,94B | 28,31B | 27,16B | 27,58B |
| Total Liabilities | 20,70B | 20,39B | 22,80B | 22,55B | 23,32B |
| Shareholders' Equity | 4,22B | 4,17B | 1,61B | 1,14B | 1,03B |
| Total Debt | 13,17B | 14,33B | 15,00B | 15,08B | 15,65B |
| Cash & Equivalents | 2,88B | 3,02B | 1,23B | 858,00M | 2,36B |
| Current Assets | 7,85B | 7,68B | 7,17B | 5,98B | 7,08B |
| Current Liabilities | 4,46B | 4,31B | 4,76B | 4,48B | 5,11B |